Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. – TTNP
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Titan Pharmaceuticals, Inc. - TTNP